Skip to main content
HYDROGEN STUDIESPOWERED BY ECHO WATER

Hydrogen Therapy and Fatty Liver Disease in Mice

Inhibition of free heme-catalyzed Fenton-like reaction prevents non-alcoholic fatty liver disease by hepatocyte-targeted hydrogen delivery

Research hubs: Digestive System

This research was done in animals. Results in animals often don't carry over to people.

Scientific visualization of hydrogen therapy research for Inhibition of free heme-catalyzed Fenton-like reaction prevents non-alcoholic fatty liver disease by hepatocyte-targeted hydrogen delivery
Evidence type
Animal study (mouse)
Authors
Min Zhao, Zhaokui Jin, Chao Xia, Shengqiang Chen, Lingting Zeng, Shucun Qin, Qianjun He
Journal
Biomaterials
Year
2023
Study Type
Mouse
Delivery
Gas (Sustained Release)
Outcome
Positive
Peer Reviewed
Yes
Cited by
51 (OpenAlex, as of November 2026)
Country
China

TL;DR

Scientists developed a new treatment that targets liver cells and releases hydrogen to stop a harmful iron-based reaction, potentially preventing the worsening of non-alcoholic fatty liver disease (NAFLD).

Key Finding

A hydrogen-delivering nanoparticle system reduced oxidative stress and prevented cell death in liver cells of mice with NAFLD by blocking harmful iron-catalyzed chemical reactions.

Summary

This study tested a new nanoparticle-based system designed to deliver hydrogen directly to liver cells in mice with non-alcoholic fatty liver disease (NAFLD—a condition where fat builds up in the liver). The researchers found that the hydrogen-delivering system reduced harmful chemical reactions in liver cells, decreased oxidative stress (cellular damage from unstable molecules), and helped remove excess iron that accumulates in NAFLD. The treatment improved liver function in the mouse model.

Practical Takeaway

This is early-stage research in mice only, not humans. While it suggests hydrogen delivery to liver cells may help prevent NAFLD progression through a specific anti-oxidant mechanism, much more research—including human trials—would be needed before any therapeutic application. The study does not evaluate hydrogen water or other consumer hydrogen products.

Abstract (excerpt)

The metabolic disorder of hepatocytes in non-alcoholic fatty liver disease (NAFLD) leads to the formation of an iron pool which induces the Fenton reaction-derived ferroptosis and the deterioration of liver disease. The elimination of the iron pool for the removal of Fenton reactions is vitally…

Read the full abstract on PubMed